Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Virus-Cell Interactions

Antigenically Distinct Conformations of CXCR4

Frédéric Baribaud, Terri G. Edwards, Matthew Sharron, Anne Brelot, Nikolaus Heveker, Ken Price, Frank Mortari, Marc Alizon, Monica Tsang, Robert W. Doms
Frédéric Baribaud
Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Terri G. Edwards
Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Sharron
Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Brelot
INSERM U332, Institut Cochin de Génétique Moléculaire, 75014 Paris, France; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nikolaus Heveker
INSERM U332, Institut Cochin de Génétique Moléculaire, 75014 Paris, France; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Price
R&D Systems, Minneapolis, Minnesota 55413
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Mortari
R&D Systems, Minneapolis, Minnesota 55413
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Alizon
INSERM U332, Institut Cochin de Génétique Moléculaire, 75014 Paris, France; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Monica Tsang
R&D Systems, Minneapolis, Minnesota 55413
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert W. Doms
Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JVI.75.19.8957-8967.2001
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig. 1.
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Binding of CXCR4 MAbs to Jurkat CD4+ cells is inhibited by T22. Binding of MAbs 12G5, 1, 2, 17, 18, and Leu3A to Jurkat CD4+ cells in the presence (thick line) or in the absence (solid black area) of T22 (40) was examined. The background binding measured with mIgGs (thin line) is also shown. The percentages of inhibition obtained in the presence of T22 in this experiment were 81.2, 88.4, 85.2, 86.5, 86.8, and 0% for 12G5, 1, 2, 17, 18, and Leu3A, respectively. FL2-H, staining obtained with the indicated MAb. A representative experiment out of three done is shown.

  • Fig. 2.
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Equilibrium binding of anti-CXCR4 MAbs. (A) Jurkat CD4+ cells were stained with the indicated concentrations of CXCR4 MAbs 12G5, 1, 2, 8, 12, 16, 17, and 18 for 1 h followed by PE-coupled anti-mouse antibody and analyzed by flow cytometry as described in Materials and Methods. A representative experiment out of three done is shown. (B) Relative affinity for each antibody presented as normalized EC50 (nEC50). The EC50 of each antibody was the concentration of antibody that gave a half-maximal GMCF value, based upon flow cytometric analysis using serial dilutions of the MAbs on Jurkat CD4+and SupT1 cells. The results are the mean and standard error of the mean obtained from three experiments with each cell type.

  • Fig. 3.
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    CXCR4 heterogeneity on lymphoid cell lines. The indicated cell lines were incubated with saturating levels of CXCR4 MAbs 12G5, 1, 2, 8, 12, 16, 17, and 18 for 1 h and then processed for flow cytometry. The cell lines are grouped into three panels (A, B, and C) for convenience. All results have been normalized to the GMCF value obtained for 12G5, which was set at 100%. The results are representative of five different experiments and are reported as the mean and standard error of the mean for each cell line.

  • Fig. 4.
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    CXCR4 heterogeneity on PBLs. Human PBLs treated for 4 days with IL-2 alone (A) or with IL-2–PHA (B) were stained with the panel of CXCR4 MAbs and analyzed by flow cytometry as described in Materials and Methods. Antibodies to CD8 and CD4 were also used to examine CXCR4 heterogeneity on these T-cell subsets. Tot., total. The results shown are the mean and standard error of the mean obtained for two or three donors in five different experiments.

  • Fig. 5.
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    CXCR4 heterogeneity on B cells. Fresh blood was stained with the panel of CXCR4 MAbs as described in Materials and Methods. All results have been normalized to the GMCF value obtained for 12G5, which was set at 100%. A representative experiment out of three done with eight donors each is shown. The mean value is indicated by a horizontal bar.

  • Fig. 6.
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Reactivity of the CXCR4 MAbs to human, rat, and feline CXCR4. (A) Amino acid sequence comparison of the amino-terminal domain (N-term.) and the first, second, and third extracellular loops (ECL1, ECL2, and ECL3) of human, rat, and feline CXCR4. Human CXCR4 is used as the reference sequence, with different amino acids in the rat or feline sequence indicated in bold. A dash indicates amino acid identity, and a dot indicates a gap created to maximize the alignment. (B) 293T cells were transfected with human, rat, or feline CXCR4, and the reactivities of MAbs 12G5, 1, 2, 8, 12, 16, 17, 18, and 4G10 were analyzed by flow cytometry. The mean and standard error of the mean for one representative experiment out of three done in triplicate are shown.

  • Fig. 7.
    • Open in new tab
    • Download powerpoint
    Fig. 7.

    Chemotaxis inhibition of T cells correlates with differential antibody reactivity. HS-Sultan cells were incubated with CXCR4 MAbs 12G5, 2, 1, 18, and 4G10. A fraction of the cells was analyzed by flow cytometry (white columns), and the rest was used for a chemotaxis assay (black columns). The mean and standard error of the mean for one representative experiment out of three done in triplicate are shown. The chemotaxis index is defined as the ratio of the number of cells that migrate under a given condition to the number of cells that migrate in the absence of the chemoattractant. NEG., chemotaxis index with no chemoattractant in the lower chamber; POS., chemotaxis in response to SDF-1α. The column labeled SDF is the chemotaxis control and shows the chemotaxis index when the concentration of SDF-1α in the upper chamber is equivalent to that in the lower chamber.

  • Fig. 8.
    • Open in new tab
    • Download powerpoint
    Fig. 8.

    Sulfation and glycosylation do not influence antibody reactivity. 293T cells were transfected with CXCR4 or a CXCR4 construct lacking the first 12 (Δ12-CXCR4), 15 (Δ15-CXCR4), or 23 (Δ23-CXCR4) N-terminal amino acids. At 48 h later, the cells were stained with MAbs 12G5, 1, 2, and 18 and analyzed by flow cytometry. A representative experiment out of three done is shown.

  • Fig. 9.
    • Open in new tab
    • Download powerpoint
    Fig. 9.

    Pertussis toxin treatment does not influence antibody reactivity. Jurkat cells were incubated overnight in the presence or absence (−) of 100 ng of pertussis toxin/ml. The cells were then stained with MAbs 12G5, 1, 2, 8, 12, 16, 17, and 18 and analyzed by flow cytometry. One experiment out of two done is shown.

Tables

  • Figures
  • Table 1.

    Reactivity of MAbs with receptor chimerasa

    MAbReactivity with the following chimera:
    4444422224444442RRRRRRHRHHRH
    12G5+−++−+−
    1+−++−+−
    2+−++−+−
    8+−++−+−
    12+−++−+−
    16+−++−+−
    17+−++−+−
    18+−++−+−
    4G10++−+−−+
    • ↵a 293T cells were transfected with plasmids expressing CXCR4 (4444) or the indicated receptor chimeras. Chimeras are designated according to the extracellular domains included in each molecule. Thus, 4222 contains the N-terminal domain of CXCR4 in a CXCR2 background. HHRH contains the second extracellular domain of rat CXCR4 in a human CXCR4 background. Cells were stained with the indicated MAbs and analyzed by FACS. +, reactive; −, not reactive.

  • Table 2.

    Recognition of CXCR4 point mutantsa

    Amino acidPositionStaining with the following antibody:
    12G5128121617184G10
    N176−−−−−−−−+
    E179−−−−−−−−+
    D181++±++++++
    D182+++++++++
    R183++++++±++
    Y184+++++++++
    I185+++++++++
    D187+++++++++
    R188+++++++++
    F189+++++++++
    D193+++++++++
    • ↵a 293T cells were transfected with plasmids expressing wild-type CXCR4 or CXCR4 mutants containing the indicated point mutations. Cells were stained with the indicated MAbs and analyzed by FACS. +, positive staining (>30% positive cells); ±, reduced staining (between 20 and 30% positive cells); −, no staining (<10% positive cells).

  • Table 3.

    Infection inhibition of T cells correlates with CXCR4 reactivitya

    MAbGMCFResult obtained with secondary antibody:
    None12G5#1#2#18
    None0100 ± 13————
    mIg8.4 ± 0.190 ± 537 ± 516 ± 349 ± 36 ± 1
    12G525.7 ± 0.740 ± 835 ± 75 ± 135 ± 45 ± 1
    170.2 ± 0.88 ± 25 ± 18 ± 14 ± 16 ± 1
    224.7 ± 0.957 ± 1435 ± 44 ± 256 ± 57 ± 1
    1886.4 ± 0.66 ± 25 ± 16 ± 17 ± 13 ± 1
    • ↵a C8166 T cells were incubated with buffer alone (None), with mIg, or with the indicated CXCR4 MAb. Alternatively, cells were further incubated with an additional CXCR4 MAb (secondary antibody) to determine if there was additive or synergistic inhibition of CXCR4-dependent virus infection. In addition, a fraction of the cells were analyzed by flow cytometry, and the remaining cells were infected with NL4-3 replication-competent luciferase reporter viruses. GMCF, geometrical mean channel fluorescence. Data are mean percentages of infection ± standard errors of the means. The results represent one experiment out of two complete experiments performed.

PreviousNext
Back to top
Download PDF
Citation Tools
Antigenically Distinct Conformations of CXCR4
Frédéric Baribaud, Terri G. Edwards, Matthew Sharron, Anne Brelot, Nikolaus Heveker, Ken Price, Frank Mortari, Marc Alizon, Monica Tsang, Robert W. Doms
Journal of Virology Oct 2001, 75 (19) 8957-8967; DOI: 10.1128/JVI.75.19.8957-8967.2001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Antigenically Distinct Conformations of CXCR4
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Antigenically Distinct Conformations of CXCR4
Frédéric Baribaud, Terri G. Edwards, Matthew Sharron, Anne Brelot, Nikolaus Heveker, Ken Price, Frank Mortari, Marc Alizon, Monica Tsang, Robert W. Doms
Journal of Virology Oct 2001, 75 (19) 8957-8967; DOI: 10.1128/JVI.75.19.8957-8967.2001
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

HIV Infections
HIV-1
Receptors, CXCR4

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514